share_log

Supernus Pharmaceuticals Q1 Sales $143.600M Miss $145.832M Estimate

Supernus Pharmaceuticals Q1 Sales $143.600M Miss $145.832M Estimate

Supernus Pharmicals第一季度銷售額爲1.436億美元,未達到1.45832億美元的預期
Benzinga ·  05/08 17:21

Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly sales of $143.600 million which missed the analyst consensus estimate of $145.832 million by 1.53 percent. This is a 6.61 percent decrease over sales of $153.764 million the same period last year.

Supernus Pharmicals(納斯達克股票代碼:SUPN)公佈的季度銷售額爲1.436億美元,比分析師普遍預期的1.45832億美元低1.53%。這比去年同期的1.53764億美元的銷售額下降了6.61%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論